Kinetics of repression by modified p53 on the PDGF β-receptor promoter

International Journal of Cancer

Volumn 123, Issue 9, 2008, Pages 2020-2030

  Yang, Weiwen ^a   Wetterskog, Daniel ^a   Matsumoto, Yoshiki ^a   Funa, Keiko ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

HDAC; p53; PDGF receptor; PML; Promoter

Indexed keywords

ACETIC ACID DERIVATIVE; BETA ACTIN; CCAAT BINDING FACTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 4; LYSINE; METHYL GROUP; MITOMYCIN; MYC PROTEIN; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN P300; PROTEIN P53; PROTEIN P73; PROTEIN TYROSINE KINASE INHIBITOR; DNA BINDING PROTEIN; HDAC1 PROTEIN, HUMAN; HDAC4 PROTEIN, HUMAN; HISTONE DEACETYLASE; MYC PROTEIN, HUMAN; NUCLEAR PROTEIN; REPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN P73;

ACETYLATION; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL COUNT; CELL NUCLEUS; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EPIGENETICS; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE MUTATION; GENE REPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; TUMOR CELL; GENETICS; KINETICS; METHYLATION; PHYSIOLOGY; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DNA-BINDING PROTEINS; HISTONE DEACETYLASES; HUMANS; KINETICS; METHYLATION; MITOMYCIN; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-MYC; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 51649114848     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23735     Document Type: Article

References (34)

1. Funa K, Uramoto H. Regulatory mechanisms for the expression and activity of platelet-derived growth factor receptor. Acta Biochim Pol 2003;50:647-58.
2. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999;79:1283-316.
3. Oster SK, Marhin WW, Asker C, Facchini LM, Dion PA, Funa K, Post M, Sedivy JM, Penn LZ. Myc is an essential negative regulator of platelet-derived growth factor beta receptor expression. Mol Cell Biol 2000;20:6768-78.
4. Izumi H, Molander C, Penn LZ, Ishisaki A, Kohno K, Funa K. Mechanism for the transcriptional repression by c-Myc on PDGF beta-receptor. J Cell Sci 2001;114:1533-44.
5. Hackzell A, Uramoto H, Izumi H, Kohno K, Funa K. p73 independently of c-Myc represses transcription ofPDGF beta-receptor through interaction with NF-Y. J Biol Chem 2002;6:6.
6. Uramoto H, Hackzell A, Wetterskog D, Ballagi A, Izumi H, Funa K. pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF beta-receptor transcription. J Cell Sci 2004;117:3855-65.
7. Silva RL, Thornton JD, Martin AC, Rehg JE, Bertwistle D, Zindy F, Skapek SX. Arf-dependent regulation of Pdgf signaling in perivascular cells in the developing mouse eye. EMBO J 2005;24:2803-14.
8. Manni I, Mazzaro G, Gurtner A, Mantovani R, Haugwitz U, Krause K, Engeland K, Sacchi A, Soddu S, Piaggio G. NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C promoters upon induced G2 arrest. J Biol Chem 2001;276:5570-6.
9. Matsui T, Katsuno Y, Inoue T, Fujita F, Joh T, Niida H, Murakami H, Itoh M, Nakanishi M. Negative regulation of Chk2 expression by p53 is dependent on the CCAAT-binding transcription factor NF-Y. J Biol Chem 2004;279:25093-100.
10. Bellorini M, Lee DK, Dantonel JC, Zemzoumi K, Roeder RG, Tora L, Mantovani R. CCAAT binding NF-Y-TBP interactions: NF-YB and NF-YC require short domains adjacent to their histone fold motifs for association with TBP basic residues. Nucleic Acids Res 1997;25:2174-81.
11. Imbriano C, Gurtner A, Cocchiarella F, Di Agostino S, Basile V, Gostissa M, Dobbelstein M, Del Sal G, Piaggio G, Mantovani R. Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters. Mol Cell Biol 2005;25:3737-51.
12. Shieh SY, Ikeda M, Taya Y, Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 1997;91:325-34.
13. Gu W, Roeder RG. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 1997;90:595-606.
14. Gostissa M, Hengstermann A, Fogal V, Sandy P, Schwarz SE, Scheffner M, Del Sal G. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J 1999;18:6462-71.
15. Chuikov S, Kurash JK, Wilson JR, Xiao B, Justin N, Ivanov GS, McKinney K, Tempst P, Prives C, Gamblin SJ, Barlev NA, Reinberg D. Regulation of p53 activity through lysine methylation. Nature 2004;432:353-60.
16. Huang J, Perez-Burgos L, Placek BJ, Sengupta R, Richter M, Dorsey JA, Kubicek S, Opravil S, Jenuwein T, Berger SL. Repression of p53 activity by Smyd2-mediated methylation. Nature 2006;444:629-32.
17. Zhong S, Salomoni P, Pandolfi PP. The transcriptional role of PML and the nuclear body. Nat Cell Biol 2000;2:E85-90.
18. Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S, Higashimoto Y, Appella E, Minucci S, Pandolfi PP, Pelicci PG. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 2000;406:207-10.
19. Ishisaki A, Murayama T, Ballagi AE, Funa K. Nuclear factor Y controls the basal transcription activity of the mouse platelet-derived-growth-factor beta-receptor gene. Eur J Biochem 1997;246:142-6.
20. Yap DB, Hsieh JK, Zhong S, Heath V, Gusterson B, Crook T, Lu X. Ser392 phosphorylation regulates the oncogenic function of mutant p53. Cancer Res 2004;64:4749-54.
21. Knights CD, Catania J, Di Giovanni S, Muratoglu S, Perez R, Swartzbeck A, Quong AA, Zhang X, Beerman T, Pestell RG, Avantaggiati ML. Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate. J Cell Biol 2006;173:533-44.
22. Mantovani R, Li XY, Pessara U, Hooft van Huisjduijnen R, Benoist C, Mathis D. Dominant negative analogs of NF-YA. J Biol Chem 1994;269:20340-6.
23. Ballagi-Pordany A, Ballagi-Pordany A, Funa K. Quantitative determination of mRNA phenotypes by the polymerase chain reaction. Anal Biochem 1991;196:89-94.
24. Watt F, Martorana A, Brookes DE, Ho T, Kingsley E, O'Keefe DS, Russell PJ, Heston WD, Molloy PL. A tissue-specific enhancer of the prostate-specific membrane antigen gene. FOLH1. Genomics 2001; 73:243-54.
25. Uramoto H, Wetterskog D, Hackzell A, Matsumoto Y, Funa K. p73 competes with co-activators and recruits histone deacetylase to NF-Y in the repression of PDGF beta-receptor. J Cell Sci 2004;117:5323-31.
26. Nakagawa T, Takahashi M, Ozaki T, Watanabe Ki K, Todo S, Mizuguchi H, Hayakawa T, Nakagawara A. Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter. Mol Cell Biol 2002;22:2575-85.
27. Molander C, Hackzell A, Ohta M, Izumi H, Funa K. Sp1 is a key regulator of the PDGF beta-receptor transcription. Mol Biol Rep 2001;28:223-33.
28. Kaeser MD, Iggo RD. Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo. Proc Natl Acad Sci USA 2002;99:95-100.
29. Frontini M, Imbriano C, Manni I, Mantovani R. Cell cycle regulation of NF-YC nuclear localization. Cell Cycle 2004;3:217-22.
30. Barlev NA, Liu L, Chehab NH, Mansfield K, Harris KG, Halazonetis TD, Berger SL. Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol Cell 2001;8:1243-54.
31. Kawaguchi Y, Ito A, Appella E, Yao TP. Charge modification at multiple C-terminal lysine residues regulates p53 oligomerization and its nucleus-cytoplasm trafficking. J Biol Chem 2006;281:1394-400.
32. Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A, Anderson CW, Appella E. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev 1998;12:2831-41.
33. Ching RW, Dellaire G, Eskiw CH, Bazett-Jones DP. PML bodies: a meeting place for genomic loci? J Cell Sci 2005;118:847-54.
34. Oren M. Decision making by p53: life, death and cancer. Cell Death Differ 2003;10:431-42.